Plasma concentrations of blood coagulation factor VII measured by immunochemical and amidolytic methods

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 60, Issue 3, 2000, Pages 161-168

  Bladbjerg, Else M ^a,b   Gram, J ^a,b   Jespersen, J ^a,b  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b ESBJERG HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 7;

ADULT; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; CORRELATION FUNCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART DEATH; HUMAN; IMMUNOCHEMISTRY; INTERMETHOD COMPARISON; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR;

EID: 0034122317     PISSN: 00365513     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655100750044802     Document Type: Article

References (21)

1. 1 Meade TW, Ruddock V, Stirling Y, Chakrabarti R, Miller GJ. Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study. Lancet 1993; 342: 1076-9.
2. 2 Junker R, Heinrich J, Schulte H, van de Loo J, Assmann G. Coagulation factor VII and the risk of coronary heart disease in healthy men. Arterioscler Thromb Vasc Biol 1997; 17: 1539-44.
3. 3 Plu-Bureau G, Scarabin PY, Bara L, Malmejac A, Guize L, Samama M. Factor VII activation and oral contraceptives. Thromb Res 1993; 70: 275-80.
4. 4 Bruckert E, de Sousa JC, Giral P, Soria C, Chapman MJ, Caen J, de Gennes JL. Interrelationship of plasma triglyceride and coagulant factor VII levels in normotriglyceridemic hypercholesterolaemia. Atherosclerosis 1989; 75: 129-34.
5. 5 Carvalho de Sousa J, Bruckert E, Giral P, Soria C, Truffert J, Mirshahi MC, de Gennes JL, Caen P. Plasma factor VII, triglyceride concentration and fibrin degradation products in primary hyperlipidaemia: a clinical and laboratory study. Haemostasis 1989; 19: 83-90.
6. 6 De Sousa JC, Bruckert E, Soria C, Caen JP. Phospholipase C sensitive factor VII activity and factor VII antigen in hypertriglyceridaemia. Nouv Rev Fr Hematol 1989; 31: 13-5.
7. 7 Hoffman C, Shah A, Sodums M, Hultin MB. Factor VII activity state in coronary artery disease. J Lab Clin Med 1988; 111: 475-81.
8. 8 Hoffman CJ, Miller RH, Lawson WE, Hultin MB. Elevation of factor VII activity and mass in young adults at risk of ischaemic heart disease. J Am Coll Cardiol 1989; 14: 941-6.
9. 9 Suzuki T, Yamauchi K, Matsushita T, Furumichi T, Furui H, Tsuzuki J, Saito H. Elevation of factor VII activity and mass in coronary artery disease of varying severity. Clin Cardiol 1991; 14: 731-6.
10. 10 Marckmann P, Sandström B, Jespersen J. Low-fat high-fiber diet favorably affects several independent risk markers of ischaemic heart disease. Observations on blood lipids, coagulation, and fibrinolysis from a trial of middle-aged Danes. Am J Clin Nutr 1994; 59: 935-9.
11. 11 Bladbjerg EM, Tholstrup T, Marckmann P, Sandström B, Jespersen J. Dietary changes in fasting levels of factor VII activity (FVII:C) are accompanied by changes in factor VII protein and other vitamin K dependent proteins. Thromb Haemost 1995; 73: 239-42.
12. 12 Marckmann P, Sandström B, Jespersen J. Effects of total fat content and fatty acid composition in diet on factor VII coagulant activity and blood lipids. Atherosclerosis 1990; 80: 227-33.
13. 13 Hoffman CJ, Miller RH, Hultin MB. Correlation of factor VII activity and antigen with cholesterol and triglycerides in healthy young adults. Arterioscler Thromb 1992; 12: 267-70.
14. 14 Boyer C, Wolf M, Rothschild C, Migaud M, Amiral J, Mannucci PM, Meyer D, Larrieu MJ. An enzyme immunoassay (ELISA) for the quantitation of human factor VII. Thromb Haemost 1986; 56: 250-5.
15. 15 Sakata T, Kario K, Matsuo T, Katayama Y, Matsuyama T, Kato H, Miyata T. Suppression of plasma-activated factor VII levels by warfarin therapy. Arterioscler Thromb Vase Biol 1995; 15: 241-6.
16. 16 Salomaa V, Rasi V, Pekkanen J, Vahtera E, Jauhiainen M, Vartiainen E, Ehnholm C, Tuomilehto J, Myllylä G. Association of hormone replacement therapy with hemostatic and other cardiovascular risk factor. The Finrisk Hemostasis Study. Arterioscler Thromb Vase Biol 1995; 15: 1549-5.
17. 17 Bladbjerg EM, Marckmann P, Sandström B, Jespersen J. Non-fasting factor VII coagulant activity (FVII:C) increased by high-fat diet. Thromb Haemost 1994; 71: 755-8.
18. 18 Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; i: 307-10.
19. 19 Hyltoft Petersen P, Stöckl D, Blaabjerg O, Pedersen B, Birkemose E, Thienpont L, Flensted Lassen J, Kjeldsen J. Graphical interpretation of analytical data from comparison of a field method with a reference method by use of difference plots. Clin Chem 1997; 43: 2039-46.
20. 20 Furie B, Furie BC. Molecular and cellular biology of blood coagulation. N Engl J Med 1992; 326: 800-6.
21. 21 Bladbjerg EM, Overgaard K, Gram J, Jespersen J. The protein concentration of blood coagulation factor VII can be measured equally well in plasma and serum. Scand J Clin Lab Invest 1995; 55: 267-71.